Genetic test allows to identify if the subject is a carrier or not of one or more of one of the variants associated with hereditary thrombophilia and this can allow to set up any preventive antithrombotic therapy, and to early identify other family members at risk.

The test identifies the five variants associated with alterations in some coagulation factors are:
Factor V Leiden is the most common cause of hereditary thrombophilia in the Caucasian population (30 – 60% of cases).
G20210A on the Factor II gene which is the second most common cause of hereditary thrombophilia in the general population.
C677T and A1298C on the MTHFR gene and 675 4G / 5G on the PAI-1 gene.

The variants determine whether or not the person is a carrier of one or more of one of the variants associated with hereditary thrombophilia.

The genetic test consists in carrying out a blood sample, in the extraction of genomic DNA and in the analysis of one or more of one of the five variants mentioned above by sequencing.

Results in 10 working days.

Analytical sensitivity and specificity > 99%.